Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.61 |
| ▸ | CNR1 | P21554 | 1/20 | 0.59 |
| ▸ | CNR2 | P34972 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | NAAA | Q02083 | 1/20 | 0.48 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.47 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19031909 | 1.00 | FAAH (0.61) | FAAHCNR1CNR2ALDH1A1LMNA | |
| SCHEMBL654707 | 1.00 | FAAH (0.61) | FAAHCNR1CNR2ALDH1A1LMNA | |
| SCHEMBL19031896 | 1.00 | FAAH (0.61) | FAAHCNR1CNR2ALDH1A1LMNA | |
| SCHEMBL29279616 | 1.00 | FAAH (0.61) | FAAHCNR1CNR2ALDH1A1LMNA | |
| Ammonia Solution, Strong SCHEMBL9998478 | 0.98 | FAAH (0.59) | FAAHCNR1CNR2ALDH1A1LMNA | |
| SCHEMBL5873220 | 0.98 | FAAH (0.58) | FAAHCNR1CNR2ALDH1A1LMNA | |
| SCHEMBL18856328 | 0.96 | FAAH (0.57) | FAAHCNR1CNR2ALDH1A1LMNA | |
| SCHEMBL20697595 | 0.96 | FAAH (0.57) | FAAHCNR1CNR2ALDH1A1LMNA | |
| SCHEMBL18856273 | 0.94 | FAAH (0.56) | FAAHCNR1CNR2ALDH1A1LMNA | |
| SCHEMBL20697592 | 0.94 | FAAH (0.56) | FAAHCNR1CNR2ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115873155-A | External electron donor composition, propylene polymerization catalytic composition and propylene polymerization method | 湖北华邦化学有限公司 | 2023-03-31 | — | — | CN | claimed |
| CN-122055369-A | Bridged tricyclic carbamoyl pyridone compounds and uses thereof | 吉利德科学公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-119998421-A | Sealant resin composition and use thereof | 三井化学株式会社 | 2025-05-13 | — | — | CN | disclosed |
| CN-119447453-A | Nonaqueous electrolyte, lithium ion battery and electricity utilization device | 宁德时代新能源科技股份有限公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-112470320-B | Nonaqueous electrolyte for battery and lithium secondary battery | 三井化学株式会社 | 2024-12-27 | — | — | CN | disclosed |
| CN-113169377-B | Nonaqueous electrolyte for battery and lithium secondary battery | 三井化学株式会社 | 2024-12-03 | — | — | CN | disclosed |
| CN-113646931-B | Nonaqueous electrolyte for battery and lithium secondary battery | 三井化学株式会社 | 2024-09-10 | — | — | CN | disclosed |
| CN-118412540-A | Nonaqueous electrolyte for battery and lithium secondary battery | 三井化学株式会社 | 2024-07-30 | — | — | CN | disclosed |
| CN-118382612-A | Method for producing blocked isocyanate compound and method for producing isocyanate compound | 旭化成株式会社 | 2024-07-23 | — | — | CN | disclosed |
| CN-115873155-B | External electron donor composition, propylene polymerization catalyst composition and propylene polymerization method | 湖北华邦化学有限公司 | 2024-04-02 | — | — | CN | disclosed |
| EP-3211706-A1 | LITHIUM SECONDARY BATTERY | Mitsui Chemicals, Inc. (JP) | 2017-08-30 | — | — | EP | disclosed |
| WO-2017112627-A1 | METHOD FOR PREPARING A MELT POLYCARBONATE | SHELL OIL COMPANY (US) | 2017-06-29 | — | — | WO | disclosed |
| WO-2017112625-A1 | METHOD FOR PRODUCING POLYCARBONATE OLIGOMERS | SHELL OIL COMPANY (US) | 2017-06-29 | — | — | WO | disclosed |
| WO-2017112626-A1 | METHOD FOR PRODUCING POLYCARBONATE | SHELL OIL COMPANY (US) | 2017-06-29 | — | — | WO | disclosed |
| EP-2573854-B1 | NON-AQUEOUS ELECTROLYTE SOLUTION CONTAINING SILYL ESTER GROUP-CONTAINING PHOSPHONIC ACID DERIVATIVE, AND LITHIUM SECONDARY BATTERY | MITSUI CHEMICALS INC (JP) | 2017-01-04 | — | — | EP | disclosed |
| US-8993158-B2 | Nonaqueous electrolyte solution containing silyl ester group-containing phosphonic acid derivative, and lithium secondary battery | MITSUI CHEMICALS, INC. (JP) | 2015-03-31 | — | — | US | disclosed |
| EP-2573854-A1 | NONAQUEOUS ELECTROLYTE SOLUTION CONTAINING SILYL ESTER GROUP-CONTAINING PHOSPHONIC ACID DERIVATIVE, AND LITHIUM SECONDARY BATTERY | Mitsui Chemicals, Inc. (JP) | 2013-03-27 | — | — | EP | disclosed |
| US-20130071732-A1 | NONAQUEOUS ELECTROLYTE SOLUTION CONTAINING SILYL ESTER GROUP-CONTAINING PHOSPHONIC ACID DERIVATIVE, AND LITHIUM SECONDARY BATTERY | MITSUI CHEMICALS, INC. (JP) | 2013-03-21 | — | — | US | disclosed |
| US-6475680-B1 | Lithium secondary battery, its electrolyte, and electric apparatus using the same | HITACHI, LTD. (JP) | 2002-11-05 | — | — | US | disclosed |
| EP-0944126-A1 | Lithium secondary battery, its electrolyte, and electric apparatus using the same | Hitachi, Ltd. (JP) | 1999-09-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130071732-A1 | NONAQUEOUS ELECTROLYTE SOLUTION CONTAINING SILYL ESTER GROUP-CONTAINING PHOSPHONIC ACID DERIVATIVE, AND LITHIUM SECONDARY BATTERY | PHOSPHO1, PSPH, SGK2 | FAAH 4023/4885CNR1 4757/4885CNR2 4785/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.